---
audienceLevel: patient
cancerTypes:
- pancreatic
- kidney
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Sunitinib Malate - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/sunitinibmalate
version: v1
---

# Sunitinib Malate - NCI

# Sunitinib Malate

Placeholder slot

(soo-NIH-tih-nib MA-layt)

This page contains brief information about sunitinib malate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Sutent

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c&audience=consumer)

## Use in Cancer

Sunitinib malate is approved to treat adults with:

- **[Gastrointestinal stromal tumor](/Common/PopUps/popDefinition.aspx?id=44998&version=Patient&language=English)**. It is used in patients whose condition has become worse while taking [imatinib mesylate](/Common/PopUps/popDefinition.aspx?id=44893&version=Patient&language=English) or who are not able to take it.
- **[Pancreatic neuroendocrine tumor](/Common/PopUps/popDefinition.aspx?id=753531&version=Patient&language=English).** It is used in patients with [progressive](/Common/PopUps/popDefinition.aspx?id=45850&version=Patient&language=English) neuroendocrine tumors that cannot be removed by surgery or have spread.
- **[Renal cell carcinoma](/Common/PopUps/popDefinition.aspx?id=661352&version=Patient&language=English)** (a type of [kidney cancer](/Common/PopUps/popDefinition.aspx?id=444995&version=Patient&language=English)). It is used:
- in patients with [advanced](/Common/PopUps/popDefinition.aspx?id=478743&version=Patient&language=English) cancer
- as [adjuvant therapy](/Common/PopUps/popDefinition.aspx?id=45587&version=Patient&language=English) in patients who have had a [nephrectomy](/Common/PopUps/popDefinition.aspx?id=46265&version=Patient&language=English) (surgery to remove the kidney) and have a high risk that the cancer will come back

Sunitinib malate is also being studied in the treatment of other types of cancer.

## More About Sunitinib Malate

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/299061) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Sunitinib Malate](https://medlineplus.gov/druginfo/meds/a607052.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

[Epigenetic Changes Pinpointed as the Cause of Some GISTs](https://www.cancer.gov/news-events/cancer-currents-blog/2019/gist-epigenetic-changes-oncogene-activation)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Sunitinib Malate](https://www.cancer.gov/research/participate/clinical-trials/intervention/C26673) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
